Cure Illnesses Such as Obesity, Diabetes, Depression, Dementia, Lupus, Autism, Heart Disease, and Cancer,” Journal of Traditional and Complementary Medicine 4, no. 2 (2014): 82–88.

248

J. Hellhammer et al., “Effects of Soy Lecithin Phosphatidic Acid and Phosphatidylserine Complex (PAS) on the Endocrine and Psychological Responses to Mental Stress,” Stress 7, no. 2 (June 2004): 119-26.

249

S. Hirayama et al., “The Effect of Phosphatidylserine Administration on Memory and Symptoms of Attention-Deficit Hyperactivity Disorder: A Randomised, Double-Blind, Placebo-Controlled Clinical Trial,” Journal of Human Nutrition and Dietetics (April 2014): 27 Suppl 2: 284-91. I. Manor et al., “The Effect of Phosphatidylserine Containing Omega-3 Fatty-Acids on Attention-Deficit Hyperactivity Disorder Symptoms in Children: A Double-Blind Placebo-Controlled Trial, Followed by an Open-Label Extension,” European Psychiatry 27, no. 5 (July 2012): 335-42.

250

Marcus Herdener et al., “Musical Training Induces Functional Plasticity in Human Hippocampus,” Journal of Neuroscience 30, no. 4 (January 2010): 1377-84. B. R. Zendel et al., “Neuroplastic Effects of Music Lessons on Hippocampal Volume in Children with Congenital Hypothyroidism,” Neuroreport 24, no. 17 (December 4, 2013): 947-50. M. S. Oechslin et al., “Hippocampal Volume Predicts Fluid Intelligence in Musically Trained People,” Hippocampus 23, no. 7 (July 2013): 552-58.

251

G. Fond, “Inflammation in Psychiatric Disorders,” European Psychiatry 29, no. 8 (November 2014): 551-52. A. H. Miller et al., “Therapeutic Implications of Brain-Immune Interactions: Treatment in Translation,” Neuropsychopharmacology 42, no. 1 (January 2017): 334-59.

252

J. C. Felger et al., “Inflammation Is Associated with Decreased Functional Connectivity within Corticostriatal Reward Circuitry in Depression,” Molecular Psychiatry 21, no. 10 (October 2016): 1358-65.

253

L. Brundin et al., “Role of Inflammation in Suicide: From Mechanisms to Treatment,” Neuropsychopharmacology 42, no. 1 (January 2017): 271-83.

254

George M. Slavich et al., “Neural Sensitivity to Social Rejection Is Associated with Inflammatory Responses to Social Stress,” Proceedings of the National Academy of Sciences of the United States of America 107, no. 33 (August 17, 2010): 14817-22.

255

C. L. Raison et al., “A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression: The Role of Baseline Inflammatory Biomarkers,” JAMA Psychiatry 70, no. 1 (January 2013): 31–41.

256

O. Köhler et al., “Inflammation and Depression: Combined Use of Selective Serotonin Reuptake Inhibitors and NSAIDs or Paracetamol and Psychiatric Outcomes,” Brain and Behavior 5, no. 8 (August 2015): e00338, doi: 10.1002/brb3.338. R. L. Iyengar et al., “NSAIDs Are Associated with Lower Depression Scores in Patients with Osteoarthritis,” American Journal of Medicine 126, no. 11 (November 2013): 1017. e11-8.

257

P. H. Wirtz and R. von Känel, “Psychological Stress, Inflammation, and Coronary Heart Disease,” Current Cardiology Reports 19, no. 11 (September 2017): 111.

258

Megan Clapp et al., “Gut Microbiota’s Effect on Mental Health: The Gut-Brain Axis,” Clinical Practice 7, no. 4 (September 15, 2017): 987.

259

Jennifer Lea Reynolds, “Is There a Connection between Gut Health and ADHD?” U.S. News & World Report, September 8, 2017, https://health.usnews.com/health-care/patient-advice/articles/2017-09-08/is-there-a-connection-between-gut-health-and-adhd.

260

C. Jiang et al., “The Gut Microbiota and Alzheimer’s Disease,” Journal of Alzheimer’s Disease 58, no. 1 (2017): 1-15, doi: 10.3233/JAD-161141. C. A. Köhler et al., “The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer’s Disease,” Current Pharmaceutical Design 22, no. 40 (2016): 6152-66.

261

Qinghui Mu et al., “Leaky Gut as a Danger Signal for Autoimmune Diseases,” Frontiers in Immunology 8 (May 23, 2017): 598.

262

Iman Salem et al., “The Gut Microbiome as a Major Regulator of the Gut-Skin Axis,” Frontiers in Microbiology 9 (July 10, 2018): 1459.

263

A. C. Logan and M. Katzman, “Major Depressive Disorder: Probiotics May Be an Adjuvant Therapy,” Medical Hypotheses 64, no. 3 (2005): 533-38.

264

A. Kato-Kataoka et al., “Fermented Milk Containing Lactobacillus casei Strain Shirota Prevents the Onset of Physical Symptoms in Medical Students under Academic Examination Stress,” Beneficial Microbes 7, no. 2 (2016): 153-56.

265

Y. Wang et al., “Effects of Alcohol on Intestinal Epithelial Barrier Permeability and Expression of Tight Junction-Associated Proteins,” Molecular Medicine Reports 9, no. 6 (June 2014): 2352-56.

266

L. Möhle et al., “Ly6C(hi) Monocytes Provide a Link between Antibiotic-Induced Changes in Gut Microbiota and Adult Hippocampal Neurogenesis,” Cell Reports 15, no. 9 (May 31, 2016): 1945-56.

267

T. A. Mori and L. J. Beilin, “Omega-3 Fatty Acids and Inflammation,” Current Atherosclerosis Reports 6, no. 6 (November 2004): 461-67. D. Moertl et al., “Dose-Dependent Effects of Omega-3-Polyunsaturated Fatty Acids on Systolic Left Ventricular Function, Endothelial Function, and Markers of Inflammation in Chronic Heart Failure of Nonischemic Origin: A Double-Blind, Placebo-Controlled, 3-Arm Study,” American Heart Journal 161, no. 5 (May 2011): 915.e1-9, doi: 10.1016/j. ahj.2011.02.011. J. G. Devassy et al., “Omega-3 Polyunsaturated Fatty Acids and Oxylipins in Neuroinflammation and Management of Alzheimer Disease,” Advances in Nutrition 7, no. 5 (September 15, 2016): 905-16.

268

“Smoking, High Blood Pressure and Being Overweight Top Three Preventable Causes of Death in the U.S.,” Harvard School of Public Health, April 27, 2009, www.hsph.harvard.edu/news/press-releases/smoking-high-blood-pressure-overweight-preventable-causes-death-us/.

269

E. Messamore et al., “Polyunsaturated Fatty Acids and Recurrent Mood Disorders: Phenomenology, Mechanisms, and Clinical Application,” Progress in Lipid Research 66 (April 2017): 1-13, doi: 10.1016/j.plipres.2017.01.001. J. Sarris et al., “Omega-3 for Bipolar Disorder: Meta-Analyses of Use in Mania and Bipolar Depression,” Journal of Clinical Psychiatry 73, no. 1 (January 2012): 81–86, doi: 10.4088/JCP.10r06710.